Coya Therapeutics, Inc. (COYA) vs Lucid Diagnostics Inc. (LUCD)
A side-by-side comparison of Coya Therapeutics, Inc. and Lucid Diagnostics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
COYA
Coya Therapeutics, Inc.
$4.91HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
LUCD
Lucid Diagnostics Inc.
$0.60HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
Total return — COYA vs LUCD
growth of $100 · dividends reinvested · last 4yCOYA +6.1% (+1.5%/yr)LUCD -57.3% (-19.2%/yr)COYA compounded faster over this window
COYA LUCD
COYA vs LUCD: by the numbers
- •COYA is the larger company ($115M vs $114M market cap).
- •Both run net losses; COYA's is the smaller (-270.22% vs -959.76% net margin).
Metrics side by side
Valuation
| Metric | COYA | LUCD |
|---|---|---|
| P/S ratio | 14.36 | 20.92 |
| P/B ratio | 0.00 | 10.42 |
Profitability
| Metric | COYA | LUCD |
|---|---|---|
| Gross margin | 99.91% | -60.26% |
| Operating margin | -255.05% | -1054.82% |
| Net margin | -270.22% | -959.76% |
| ROE | -0.05% | -478.26% |
| ROIC | -0.05% | -145.10% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.